Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidefumi Kasai

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|April 27, 2025
Population pharmacokinetic analysis of the interaction of digoxin with N-desethylamiodarone in patients with atrial fibrillation and heart failureToshinori Hirai, Hidefumi Kasai, Tsuyoshi Shiga
Cancer Chemotherapy and Pharmacology|September 15, 2020
Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancerTakahiro Tsushima, Hidefumi Kasai, Yusuke Tanigawara
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2021
Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance dataYuki Otani, Hidefumi Kasai, Yusuke Tanigawara
CPT: Pharmacometrics & Systems Pharmacology|October 22, 2021
Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance dataYuki Otani, Hidefumi Kasai, Yusuke Tanigawara
CPT: Pharmacometrics & Systems Pharmacology|March 31, 2026
SCOUT: An Exploratory Approach to Scouting Dose-Relevant CovariatesYasuhisa Ideno, Hidefumi Kasai, Yusuke Tanigawara
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Generating and Modeling Virtual Patient Data from Published Population Pharmacokinetic Analyses: A Vancomycin Case StudyMoeko Suzuki, Hidefumi Kasai, Takahiko Aoyama, et al.
Therapeutic Drug Monitoring|September 18, 2020
Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage OptimizationPrawat Chantharit, Montira Tantasawat, Hidefumi Kasai, et al.
Journal of Clinical Pharmacology|November 2, 2020
Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic AcidHidefumi Kasai, Yoko Mori, Atsushi Ose, et al.
Drug Metabolism and Pharmacokinetics|May 19, 2018
An analysis on distribution and inter-relationships of biomarkers under rivaroxaban in Japanese patients with non-valvular atrial fibrillation (CVI ARO 1)Shinya Suzuki, Takeshi Yamashita, Hidefumi Kasai, et al.
BMC Pharmacology & Toxicology|February 11, 2022
Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world dataToshinori Hirai, Hidefumi Kasai, Miyoko Naganuma, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|April 27, 2025
Population pharmacokinetic analysis of the interaction of digoxin with N-desethylamiodarone in patients with atrial fibrillation and heart failureToshinori Hirai, Hidefumi Kasai, Tsuyoshi Shiga
Cancer Chemotherapy and Pharmacology|September 15, 2020
Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancerTakahiro Tsushima, Hidefumi Kasai, Yusuke Tanigawara
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2021
Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance dataYuki Otani, Hidefumi Kasai, Yusuke Tanigawara
CPT: Pharmacometrics & Systems Pharmacology|October 22, 2021
Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance dataYuki Otani, Hidefumi Kasai, Yusuke Tanigawara
CPT: Pharmacometrics & Systems Pharmacology|March 31, 2026
SCOUT: An Exploratory Approach to Scouting Dose-Relevant CovariatesYasuhisa Ideno, Hidefumi Kasai, Yusuke Tanigawara
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Generating and Modeling Virtual Patient Data from Published Population Pharmacokinetic Analyses: A Vancomycin Case StudyMoeko Suzuki, Hidefumi Kasai, Takahiko Aoyama, et al.
Therapeutic Drug Monitoring|September 18, 2020
Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage OptimizationPrawat Chantharit, Montira Tantasawat, Hidefumi Kasai, et al.
Journal of Clinical Pharmacology|November 2, 2020
Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic AcidHidefumi Kasai, Yoko Mori, Atsushi Ose, et al.
Drug Metabolism and Pharmacokinetics|May 19, 2018
An analysis on distribution and inter-relationships of biomarkers under rivaroxaban in Japanese patients with non-valvular atrial fibrillation (CVI ARO 1)Shinya Suzuki, Takeshi Yamashita, Hidefumi Kasai, et al.
BMC Pharmacology & Toxicology|February 11, 2022
Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world dataToshinori Hirai, Hidefumi Kasai, Miyoko Naganuma, et al.
Pageof 4